Readnour Robin Shane

Track

Insider profile

Performance

Overall performance
2.7
Performance over holding periods
2.7
30 days 90 days 120 days
Average return 8% 8.2% 15.1%
Success rate 70% 68% 82%
Transactions
14 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Readnour Robin Shane's trades of AN2 Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-10 2024-12-10
B Purchase
5,187 +34.9%
115.36
US$4,133,199 		5,187 +34.9% 115.36 US$4,133,199
2024-12-10 2024-12-10
B Purchase
2,861 +34.0%
422.86
US$1,735,502 		2,861 +34.0% 422.86 US$1,735,502
2024-12-10 2024-12-09
B Purchase
39,740 -7.3%
357.36
US$3,901,579 		39,740 -7.3% 357.36 US$3,901,579
2024-12-10 2024-12-09
B Purchase
12,289 +2.2%
1.43
US$17,577 		12,289 +2.2% 1.43 US$17,577
2024-12-10 2024-12-06
B Purchase
6,517 +1.0%
1.45
US$9,427 		6,517 +1.0% 1.45 US$9,427
2024-12-10 2024-12-06
B Purchase
12,711 +2.3%
1.45
US$18,367 		12,711 +2.3% 1.45 US$18,367
2024-11-27 2024-11-27
B Purchase
25,000 +4.2%
1.42
US$35,418 		25,000 +4.2% 1.42 US$35,418
2024-11-27 2024-11-27
B Purchase
25,000 +4.7%
1.42
US$35,422 		25,000 +4.7% 1.42 US$35,422
2024-11-27 2024-11-26
B Purchase
12,500 +2.1%
1.39
US$17,428 		12,500 +2.1% 1.39 US$17,428
2024-11-27 2024-11-26
B Purchase
12,500 +2.4%
1.39
US$17,418 		12,500 +2.4% 1.39 US$17,418
2024-11-21 2024-11-20
B Purchase
25,000 +5.1%
1.15
US$28,870 		25,000 +5.1% 1.15 US$28,870
2024-11-21 2024-11-20
B Purchase
25,000 +4.5%
1.16
US$29,000 		25,000 +4.5% 1.16 US$29,000
2024-11-21 2024-11-19
B Purchase
75,000 +18.1%
1.04
US$77,730 		75,000 +18.1% 1.04 US$77,730
2024-11-21 2024-11-19
B Purchase
75,000 +15.5%
1.03
US$77,528 		75,000 +15.5% 1.03 US$77,528
2024-01-17 2024-01-12
PlS Planned sale
719 -0.1%
21.91
US$15,753 		719 -0.1% 21.91 US$15,753
2024-01-17 2024-01-12
PlS Planned sale
706 -0.2%
21.92
US$15,476 		706 -0.2% 21.92 US$15,476
2024-01-12 2024-01-10
PlS Planned sale
1,800 -0.4%
21.92
US$39,456 		1,800 -0.4% 21.92 US$39,456
2024-01-12 2024-01-10
PlS Planned sale
1,869 -0.4%
21.93
US$40,987 		1,869 -0.4% 21.93 US$40,987